BurnsL. R., HousmanM. G., BoothR. E.Jr., KoenigA. (2009). Implant vendors and hospitals: Competing influences over product choice by orthopedic surgeons. Health Care Management Review, 34(1), 2–18. 10.1097/01.HMR.0000342984.22426.ac
3.
FuchshuberP., JonesS., JonesD., FeldmanL. S., SchwaitzbergS., RoznerM. A. (2013). Ensuring safety in the operating room: The "fundamental use of surgical energy" (FUSE) program. International Anesthesiology Clinics, 51(4), 65–80. 10.1097/AIA.0b013e3182a70903
4.
FuchshuberP., SchwaitzbergS., JonesD., JonesS. B., FeldmanL., MunroM., RobinsonT., Purcell-JacksonG., MikamiD., MadaniA., BruntM., DunkinB., GugliemiC., GroahL., LimR., MischnaJ., & VoylesC. R. (2018). The SAGES Fundamental Use of Surgical Energy program (FUSE): History, development, and purpose. Surgical Endoscopy, 32(6), 2583–2602. 10.1007/s00464-017-5933-y
5.
GagliardiA. R., LehouxP., DuceyA., EastyA., RossS., BellC., TrbovichP., & UrbachD. R. (2017). “We can't get along without each other”: Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety. PLoS One, 12(3), e0174934. 10.1371/journal.pone.0174934
6.
GrundyQ. (2018). Infiltrating healthcare: How marketing works underground to influence nurses. Johns Hopkins University Press.
7.
GrundyQ., HutchisonK., JohnsonJ., BlakelyB., Clay-WlliamsR., RichardsB., & RogersW. A. (2018). Device representatives in hospitals: Are commercial imperatives driving clinical decision-making?Journal of Medical Ethics, 44(9), 589–592. 10.1136/medethics-2018-104804
8.
GrundyQ., MillingtonA., CussenC., HeldF., & DaleC. M. (2020). Promotion or education: A content analysis of industry-authored oral health educational materials targeted at acute care nurses. BMJ Open, 10(11), e040541. 10.1136/bmjopen-2020-040541
9.
JohnsonJ., & HutchisonK. (2018). They know how to work it, that's their focus in life: The complex role of industry representatives in surgical innovation. Journal of Empirical Research on Human Research Ethics, 13, 461–474. 10.1177/1556264618785037
10.
MaddenM. (2012). Alienating evidence based medicine vs. innovative medical device marketing: A report on the evidence debate at a wounds conference. Social Science & Medicine, 74(12), 2046–2052. http://dx.doi.org/10.1016/j.socscimed.2012.02.026
11.
MaddenM., & StarkJ. (2019). Understanding the development of advanced wound care in the UK: Interdisciplinary perspectives on care, cure and innovation. Journal of Tissue Viability, 28, 107–114. 10.1016/j.jtv.2019.03.003
12.
MillerF. A., LehouxP., PeacockS., RacV. E., NeukommJ., BargC., BytautasJ. P., & KrahnM. (2019). How procurement judges the value of medical technologies: A review of healthcare tenders. International Journal of Technology Assessment in Health Care, 35(1), 50–55. 10.1017/S0266462318003756
13.
NicholasB. J. (2017). Promoting a culture of collaboration between point-of-care clinicians and industry partners. Journal of Medical Marketing, 16(1):21–34. 10.1177/1745790417732488
14.
O'ConnorB., PollnerF., & Fugh-BermanA. (2016). Salespeople in the surgical suite: Relationships between surgeons and medical device representatives. PLoS One, 11(8), e0158510. 10.1371/journal.pone.0158510
15.
SudarskyD., CharaniaJ., InmanA., D'AlfonsoS., & LaviS. (2013). The impact of industry representative's visits on utilization of coronary stents. American Heart Journal, 166(2), 258–265. http://dx.doi.org/10.1016/j.ahj.2013.05.011